s-nitrosoglutathione has been researched along with Complications of Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, F; Al-Qahtani, M; Alkhatabi, H; Hoda, MN; Zaidi, SK | 1 |
| Burrow, JW; Chuang, HH; Dean, DD; Koch, JA; Sylvia, VL; Zhong, W | 1 |
2 other study(ies) available for s-nitrosoglutathione and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Nebulization of Low-Dose S-Nitrosoglutathione in Diabetic Stroke Enhances Benefits of Reperfusion and Prevents Post-Thrombolysis Hemorrhage.
Topics: Animals; Behavior, Animal; Blood Pressure; Blood-Brain Barrier; COVID-19; Diabetes Complications; Diabetes Mellitus; Hemorrhage; Hypoxia; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Microcirculation; Nebulizers and Vaporizers; Neuroprotective Agents; Perfusion; Reperfusion Injury; Risk; S-Nitrosoglutathione; Stress, Mechanical; Stroke; Thrombolytic Therapy | 2021 |
Nitric oxide donors selectively reduce the expression of matrix metalloproteinases-8 and -9 by human diabetic skin fibroblasts.
Topics: Cell Division; Cells, Cultured; Diabetes Complications; Female; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Male; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Skin; Skin Ulcer; Time Factors; Wound Healing | 2007 |